ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

The S&P/ASX 200 fell 0.4% by mid-morning Wednesday, led by declines in tech and banks, while miners rose on record gold prices near $4,762 an ounce. U.S. President Trump threatened new tariffs on eight European countries after their troops arrived in Greenland, escalating trade tensions. Lynas Rare Earths jumped on a 43% revenue surge. Rio Tinto reported record quarterly iron ore shipments.
Morgan Stanley stock drops 3.7% after-hours as rate-cap deadline and tariff jitters hit banks

Morgan Stanley stock drops 3.7% after-hours as rate-cap deadline and tariff jitters hit banks

Morgan Stanley shares fell 3.7% to $182.10 Tuesday, tracking a broader drop in U.S. bank stocks after the Trump administration threatened a 10% cap on credit-card interest rates. Trading volume doubled its 50-day average. The S&P 500 lost 2.06%. Morgan Stanley’s board declared a $1.00 quarterly dividend, payable Feb. 13 to shareholders of record Jan. 30.
21 January 2026
Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites

Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites

Bank of America shares fell 1.64% to $52.10 Tuesday, then held steady after hours. The bank announced a $1 billion employee stock grant, totaling nearly 19 million shares. Investors weighed the move against uncertainty over a possible 10% federal cap on credit-card interest rates. CEO Brian Moynihan sold and repurchased about 17,900 shares last week, according to SEC filings.
21 January 2026
Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

Corvus Pharmaceuticals shares soared over 167% to $21.41 in after-hours trading Tuesday after reporting positive placebo-controlled trial results for its experimental eczema pill. The company launched a $150 million underwritten stock and warrant offering following the data release. Analysts raised price targets. About 84 million shares changed hands.
Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum shares rose about 10% Tuesday, closing at $356.83 and holding steady after hours. Aletheia Capital’s Skye Chen raised his price target to $500, citing stronger demand for high-speed data-center lasers. Lumentum reports fiscal Q2 results Feb. 3 after the market closes. The company will also present new laser platforms at SPIE Photonics West this week.
Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

Applied Materials fell 2.7% to $318.23 Tuesday, mirroring a sharp drop in semiconductor stocks and the S&P 500. The decline came despite Needham raising its price target to $390, citing stronger demand. Shares traded between $314.58 and $324.35 on volume of 9.4 million. Investors await earnings from ASML and KLA next week, with Applied’s own report due Feb. 12.
21 January 2026
RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

Rapt Therapeutics shares surged 64% to $57.57 in after-hours trading after GSK agreed to acquire the company for $58 a share in cash, valuing Rapt at about $2.2 billion. The deal centers on ozureprubart, a long-acting anti-IgE antibody. GSK plans to launch a tender offer within 10 business days. Closing depends on a majority of Rapt shares being tendered and U.S. antitrust clearance.
Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus

Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus

Goldman Sachs shares fell 1.9% to $943.37 in after-hours trading Tuesday as investors awaited a White House decision on capping credit card interest rates. Bank stocks broadly declined, with JPMorgan down 3.1% and Citigroup off 4.4%. Goldman also announced a new deal with the Qatar Investment Authority to raise up to $25 billion for managed funds and co-investments. RBC Capital raised its price target on Goldman to $1,030.
Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Coinbase shares fell 5.5% to $227.73 in after-hours trading Tuesday after bitcoin dropped 4.6% to about $88,312. CEO Brian Armstrong, speaking in Davos, said he remains optimistic about U.S. crypto legislation despite recent setbacks. Bermuda announced plans for a fully onchain national economy using Circle and Coinbase infrastructure, drawing regulatory attention.
Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research shares closed down 0.25% Tuesday, holding near $222 in muted after-hours trading as tariff threats from President Trump pressured tech stocks. UBS raised its price target on Lam to $255, citing strong Q2 prospects. Lam’s earnings report is set for Jan. 28. Applied Materials and KLA fell more sharply, dropping 2.7% and 5.2% respectively.
Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Eli Lilly shares closed up 0.3% at $1,041.29 Tuesday and rose slightly after hours after the FDA granted Breakthrough Therapy status to its ovarian cancer drug candidate, sofetabart mipitecan. The designation targets adults with platinum-resistant ovarian cancer. Analyst Seamus Fernandez maintained a buy rating but trimmed his price target. Abivax’s CEO denied rumors of takeover talks with Lilly.
21 January 2026
Bloom Energy stock price swings after-hours as RBC flags Texas data-center permit

Bloom Energy stock price swings after-hours as RBC flags Texas data-center permit

Bloom Energy shares rose 1.5% to $151.75 in after-hours trading Tuesday after RBC reaffirmed its Outperform rating and $143 price target, citing an air-permit filing for a 1.5-gigawatt Texas data center project. Bloom also released a survey showing increased demand for onsite power at data centers. The stock swung between $138.68 and $155.03 during the session.
Salesforce stock (CRM) slides after hours as Trump tariff threat hits tech — what’s next

Salesforce stock (CRM) slides after hours as Trump tariff threat hits tech — what’s next

Salesforce shares fell 3.1% to near $220 in after-hours trading Tuesday, extending an eight-session slide. The drop followed a broad tech selloff after President Trump renewed tariff threats tied to Greenland, sending the Dow down 1.76%. Trading volume for Salesforce hit 13 million shares, well above average. The stock now trades nearly 40% below its January 2025 peak.
21 January 2026
Costco stock price steadies after hours as tariff threat rattles markets

Costco stock price steadies after hours as tariff threat rattles markets

Costco shares edged up 0.1% to $964.26 in after-hours trading Tuesday, holding steady as Wall Street posted its sharpest drop in three months after a new U.S. tariff threat on Europe. Directors Susan L. Decker and Gina Marie Raimondo disclosed minor insider transactions. December net sales rose 8.5% to $29.86 billion. Costco will pay a $1.30 dividend on Feb. 13 and report Q2 results March 5.
21 January 2026
Lululemon pulls “Get Low” leggings from its website after sheer complaints, stock drops

Lululemon pulls “Get Low” leggings from its website after sheer complaints, stock drops

Lululemon halted online sales of its new “Get Low” leggings in North America after customers complained the fabric was see-through during movement. The stock fell about 6% Tuesday as the move raised concerns over product quality and leadership changes. The collection remains available in stores while the company reviews feedback. CEO Calvin McDonald steps down at the end of January.
21 January 2026
Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson stock price slips after-hours ahead of earnings as tariff fears rattle markets

Johnson & Johnson shares slipped 0.2% to $218.21 in after-hours trading Tuesday ahead of quarterly earnings due Wednesday. The move followed a broad market selloff, with the Dow down 1.76% and the S&P 500 off 2.06% after new U.S. tariff threats. Analysts expect Q4 profit of $2.47 per share. The company faces ongoing litigation, including a $1.5 billion verdict over talc products.

Stock Market Today

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

8 February 2026
Cambricon Technologies shares closed at 1,036.99 yuan in Shanghai on Friday, down 2.02%, with volume at about 8 million shares. The stock has fallen roughly 16.5% since Feb. 2 after sharp declines earlier in the week. Investors await the company’s next earnings report, due March 13, for confirmation of its forecasted profit turnaround. Cambricon is valued at about 437.28 billion yuan.
Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

Infineon stock in focus after Friday rise as reports flag April price hikes for power chips

8 February 2026
Infineon shares closed up 1.5% at 42.04 euros Friday on Xetra after reports the company plans April price hikes on some power products. TrendForce said the increases, citing tight supply and higher costs, would apply from April 1. The Feb. 12 record date and Feb. 19 annual meeting are next for shareholders. UBS raised its price target to 47 euros, citing stronger margins.
TE Connectivity stock jumps 3.5% into the weekend — what to watch for TEL next week

TE Connectivity stock jumps 3.5% into the weekend — what to watch for TEL next week

8 February 2026
TE Connectivity (NYSE: TEL) closed Friday up 3.46% at $215.91, rebounding after a 3.29% drop Thursday, but remains 5% lower for the week and 14% below its 52-week high. The company expects to close a $750 million senior notes offering on Monday and pay a $0.71 dividend March 13. Investors await Friday’s U.S. CPI report, seen as a key market driver.
Go toTop